NEWS: Cohn & Wolfe chosen for Flixotide

Cohn and Wolfe has scooped the estimated pounds 200,000 fee account from Glaxo Wellcome subsidiary Allen and Hanburys to promote its asthma drug Flixotide.

Cohn and Wolfe has scooped the estimated pounds 200,000 fee account from

Glaxo Wellcome subsidiary Allen and Hanburys to promote its asthma drug

Flixotide.



Appointed last week, the agency won the account after a lengthy pitch

process against three other specialist healthcare consultancies.



The pitch process itself was prompted by the decision in March to drop

Shire Hall from the Flixotide account following a disagreement between

agency and client over the level of PR activity being undertaken on

behalf of the drug.



With an overall annual budget of pounds 300,000 at its disposal, Cohn

and Wolfe will manage a media relations programme targeted at GPs and

practice nurses, emphasising Flixotide’s effectiveness and safety as an

inhaled steroid.



‘The key issue is to re-educate parents on the use of steroids for

asthma,’ explained Martin Ellis, director of Cohn and Wolfe’s healthcare

division. ‘We will be identifying ways of helping GPs overcome parental

steroid phobia and position it as a strongly effective drug.’



Approved and marketed in over 30 countries, Flixotide is used to treat

patients aged 12 years and over. One of Glaxo Wellcome’s biggest

earners, it achieved sales worth pounds 30 million in the first half of

1995.



Flixotide is Cohn and Wolfe’s fifth Glaxo Wellcome drug account. It

already manages PR for Zantac and Pylorid ulcer treatments, Zofran anti-

sickness treatment and the Wellseron cancer drug.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

John Lewis to tell brand story with "tasteful" 150th anniversary celebrations

John Lewis to tell brand story with "tasteful" 150th anniversary celebrations

Department store John Lewis is to use its 150th anniversary this year to talk about its history, which "not enough people know about", according to director of communications Peter Cross.

Labour hires Obama election strategist David Axelrod to fight General Election

Labour hires Obama election strategist David Axelrod to fight General Election

The man who helped Barack Obama win the 2008 and 2012 US presidential elections is to work for Labour along with members of his team.

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.